ALZHEIMER'S CLINICAL TRIAL

WVU Rockefeller Neuroscience Institute pioneers promising new Alzheimer’s therapy.

An interdisciplinary research team at the West Virginia University Rockefeller Neuroscience Institute became the first in the world to use focused ultrasound to treat a patient with Alzheimer’s disease. View press release.

If you would like further details regarding the INSIGHTEC ExAblate Neuro Alzheimer’s research study study, please contact the Rockefeller Neuroscience Institute by calling 304-293-5150 or email us at WVURNI@hsc.wvu.edu. The information you provide will not be shared with anyone other than personnel directly involved with the research study.

More than five million Americans suffer from Alzheimer’s Disease, yet no cure or effective treatment has been found yet. WVU has been selected as the first site in the world for an innovative clinical trial to treat Alzheimer’s Disease.

For more information or to schedule an appointment,
call 855-WVU-CARE (855-988-2273).

MAKE AN APPOINTMENT

855-WVU-CARE

FEATURED STORY

Judi’s Journey with Alzheimer’s

Neurological surgeons, neurologists, and neuropsychologists at the West Virginia University Rockefeller Neuroscience Institute were the first in the world to use focused ultrasound to treat a patient with Alzheimer’s disease. Judi is the first patient to undergo the phase II clinical trial led by Dr. Ali Rezai, the Institute’s leader.

Watch Judi’s Story